Aurora Cannabis (TSE:ACB) Trading 12.3% Higher

Aurora Cannabis Inc. (TSE:ACB) rose 12.3% during trading on Friday . The company traded as high as C$10.31 and last traded at C$10.29. Approximately 1,189,600 shares changed hands during trading, a decline of 8% from the average daily volume of 1,299,698 shares. The stock had previously closed at C$9.16.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on ACB shares. CIBC cut their target price on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Jefferies Financial Group lowered their price objective on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating for the company in a research report on Tuesday, February 27th. Finally, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 target price on the stock in a report on Friday, February 9th.

Aurora Cannabis Trading Up 0.3 %

The stock has a market cap of C$501.22 million, a PE ratio of -0.12 and a beta of 2.83. The company has a debt-to-equity ratio of 18.51, a quick ratio of 2.48 and a current ratio of 3.79. The stock has a fifty day moving average price of C$6.28 and a 200 day moving average price of C$2.58.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings results on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C($0.10) by C($0.10). The company had revenue of C$72.61 million during the quarter, compared to the consensus estimate of C$63.50 million. Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. Equities analysts expect that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.